Full marks to Joel's delivery on yesterday's interview. Spoke well, precisely and showed confidence. Interim results in the near future as promised in Sydney and to say this, dosing seems to be assured at this point of development moving IHL-42X into late stage development. As mentioned previously if Incannex can commence dosing April/May we should have interims announced/updates during H2.
ref: Reddit/Incannex
Incannex.com for full update.
